NL190581C - 7beta-(D-2-amino-2-fenylaceetamido)-3-(propenyl)-3-cefem-4-carbonzuur verbinding en farmaceutisch preparaat dat deze verbinding omvat. - Google Patents

7beta-(D-2-amino-2-fenylaceetamido)-3-(propenyl)-3-cefem-4-carbonzuur verbinding en farmaceutisch preparaat dat deze verbinding omvat.

Info

Publication number
NL190581C
NL190581C NL8400229A NL8400229A NL190581C NL 190581 C NL190581 C NL 190581C NL 8400229 A NL8400229 A NL 8400229A NL 8400229 A NL8400229 A NL 8400229A NL 190581 C NL190581 C NL 190581C
Authority
NL
Netherlands
Prior art keywords
compound
7beta
phenylacetamido
cephem
propenyl
Prior art date
Application number
NL8400229A
Other languages
English (en)
Dutch (nl)
Other versions
NL8400229A (nl
NL190581B (nl
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27040143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL190581(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NL8400229A publication Critical patent/NL8400229A/nl
Publication of NL190581B publication Critical patent/NL190581B/xx
Application granted granted Critical
Publication of NL190581C publication Critical patent/NL190581C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8400229A 1983-01-28 1984-01-25 7beta-(D-2-amino-2-fenylaceetamido)-3-(propenyl)-3-cefem-4-carbonzuur verbinding en farmaceutisch preparaat dat deze verbinding omvat. NL190581C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46183383A 1983-01-28 1983-01-28
US46183383 1983-01-28
US06/564,604 US4520022A (en) 1983-01-28 1983-12-28 Substituted vinyl cephalosporins
US56460483 1983-12-28

Publications (3)

Publication Number Publication Date
NL8400229A NL8400229A (nl) 1984-08-16
NL190581B NL190581B (nl) 1993-12-01
NL190581C true NL190581C (nl) 1994-05-02

Family

ID=27040143

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8400229A NL190581C (nl) 1983-01-28 1984-01-25 7beta-(D-2-amino-2-fenylaceetamido)-3-(propenyl)-3-cefem-4-carbonzuur verbinding en farmaceutisch preparaat dat deze verbinding omvat.

Country Status (32)

Country Link
US (1) US4520022A (ko)
AR (1) AR240824A1 (ko)
AT (1) AT383351B (ko)
BE (1) BE898778A (ko)
CA (3) CA1233815A (ko)
CH (1) CH661731A5 (ko)
CY (1) CY1528A (ko)
CZ (1) CZ280411B6 (ko)
DD (2) DD228261A5 (ko)
DE (1) DE3402642A1 (ko)
DK (1) DK162052C (ko)
ES (2) ES529171A0 (ko)
FI (2) FI79540C (ko)
FR (1) FR2540117B1 (ko)
GB (1) GB2135305B (ko)
GR (1) GR79791B (ko)
HK (1) HK73690A (ko)
HU (1) HU191990B (ko)
IE (1) IE56784B1 (ko)
IL (1) IL70773A (ko)
IT (1) IT1218842B (ko)
LU (1) LU85184A1 (ko)
NL (1) NL190581C (ko)
NO (1) NO165027C (ko)
NZ (1) NZ206973A (ko)
OA (1) OA07643A (ko)
PT (1) PT78020B (ko)
SE (2) SE458611B (ko)
SK (1) SK61684A3 (ko)
SU (1) SU1407400A3 (ko)
YU (1) YU44393B (ko)
ZW (1) ZW1184A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM884A1 (en) * 1983-01-28 1984-10-22 Bristol Myers Co Substituted vinyl cephalosporins
GB8411954D0 (en) * 1984-05-10 1984-06-13 Glaxo Group Ltd Cephalosporin antibiotics
FR2580652B1 (fr) * 1985-04-22 1989-01-06 Bristol Myers Co Acide 7-amino-3-propenylcephalosporanique et ses esters
US4699979A (en) * 1985-04-22 1987-10-13 Bristol-Meyers Company 7-amino-3-propenylcephalosporanic acid and esters thereof
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
US4694079A (en) * 1985-07-29 1987-09-15 Bristol-Myers Company 3-propenyl cephalosporin solvates
US4619925A (en) * 1985-11-08 1986-10-28 Bristol-Myers Company 3-Propenyl cephalosporin derivatives
US4727070A (en) * 1985-11-25 1988-02-23 Bristol-Myers Company 3-Propenzl cephalosporin isomer separation process and derivative
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
DE3734004A1 (de) * 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3734005A1 (de) * 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5128336A (en) * 1988-03-23 1992-07-07 Eli Lilly And Company 3-(substituted)-1-carba(dethia)-3-cephems
US5245027A (en) * 1989-11-21 1993-09-14 Bristol-Myers Squibb Company 3-fluorosulfonyloxyceph-3-em compounds
JP2825655B2 (ja) * 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー ３−セフェム−４−カルボン酸誘導体の精製方法
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
WO2004110399A2 (en) * 2003-06-19 2004-12-23 Ranbaxy Laboratories Limited Solvates of cefprozil
US7544797B2 (en) 2003-10-30 2009-06-09 Cj Cheiljedang Corporation Processes for the preparation of cephem derivatives
US20070072945A1 (en) * 2004-03-31 2007-03-29 Pohoreski Anton Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
EP1809638B1 (en) * 2004-11-01 2010-02-17 Hetero Drugs Limited A novel process for preparation of cefprozil intermediate
WO2009049086A1 (en) * 2007-10-09 2009-04-16 Larry Sutton Broad spectrum beta-lactamase inhibitors
TR201000689A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Sefprozil içeren katı dozaj formlar.
WO2013109201A1 (en) 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising cefprozil and clavulanic acid
JP6403289B2 (ja) 2013-03-12 2018-10-10 グラディウス ファーマシューティカルズ コーポレーションＧｌａｄｉｕｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ 誘導体化３−スチリル−セファロスポリン

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3351596A (en) * 1966-09-21 1967-11-07 Lilly Co Eli 3-formyl cephalosporins
US3489750A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
US3485819A (en) * 1968-07-02 1969-12-23 Squibb & Sons Inc Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins
US3769277A (en) * 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
US3994884A (en) * 1970-01-23 1976-11-30 Glaxo Laboratories Limited 3-Vinyl-7β-(2,2-disubstituted acetamido)-cephalosporins
US4107431A (en) * 1970-01-23 1978-08-15 Glaxo Laboratories Limited Δ3 -3-Vinyl or substituted vinyl-4-carboxy cephalosporins
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US3674784A (en) * 1970-07-27 1972-07-04 Lilly Co Eli 3-formyl cephalosporin sulfoxides
US4065620A (en) * 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
BE789817A (fr) 1971-10-07 1973-04-06 Glaxo Lab Ltd Perfectionnements aux composes de cephalosporine
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
GB1472174A (en) * 1973-09-22 1977-05-04 Beecham Group Ltd Dihydroxy amino cephalosporins
FR2264021A1 (en) * 1974-03-13 1975-10-10 Aries Robert Cephalosporanic acid antibiotics - from alpha amino phenyl acetic acids and phosphorus trihalide then a 7-amino cepheme
JPS5129492A (en) * 1974-09-04 1976-03-12 Sankyo Co Sefuarosuhorinjudotai no seiho
US4049806A (en) * 1975-08-15 1977-09-20 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
US3983113A (en) * 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
US4094978A (en) * 1976-07-29 1978-06-13 Syntex (U.S.A.) Inc. 3-propenyl derivatives of cephalosporin, compositions and their use
US4112087A (en) * 1976-11-04 1978-09-05 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials having a substituted propenyl group in the 3-position
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
ES535953A0 (es) 1985-10-01
ES8505206A1 (es) 1985-05-16
FI840300A (fi) 1984-07-29
NO840334L (no) 1984-07-30
SE8703153D0 (sv) 1987-08-13
FR2540117B1 (fr) 1987-03-20
FI79540B (fi) 1989-09-29
DK35384D0 (da) 1984-01-26
ES529171A0 (es) 1985-05-16
FI881929A (fi) 1988-04-25
AU2357584A (en) 1984-08-02
HK73690A (en) 1990-09-28
HU191990B (en) 1987-04-28
FI840300A0 (fi) 1984-01-25
SE8400419D0 (sv) 1984-01-27
SU1407400A3 (ru) 1988-06-30
FI81356C (fi) 1990-10-10
ZW1184A1 (en) 1984-08-29
US4520022A (en) 1985-05-28
NO165027B (no) 1990-09-03
PT78020B (en) 1986-06-02
YU44393B (en) 1990-06-30
CH661731A5 (de) 1987-08-14
IE840026L (en) 1984-07-28
CA1225084A (en) 1987-08-04
IT8419346A0 (it) 1984-01-27
IT1218842B (it) 1990-04-24
BE898778A (fr) 1984-07-27
NZ206973A (en) 1987-03-06
YU14084A (en) 1987-06-30
SE8703153L (sv) 1987-08-13
IL70773A0 (en) 1984-04-30
GB8402255D0 (en) 1984-02-29
CA1233815A (en) 1988-03-08
SE466204B (sv) 1992-01-13
AR240824A2 (es) 1991-02-28
CY1528A (en) 1990-11-16
DE3402642C2 (ko) 1989-11-09
FR2540117A1 (fr) 1984-08-03
DK162052C (da) 1992-02-10
CZ280411B6 (cs) 1996-01-17
NL8400229A (nl) 1984-08-16
DD228261A5 (de) 1985-10-09
AT383351B (de) 1987-06-25
OA07643A (fr) 1985-05-23
FI881929A0 (fi) 1988-04-25
DD222029A5 (de) 1985-05-08
SK278845B6 (sk) 1998-03-04
NO165027C (no) 1990-12-12
PT78020A (en) 1984-02-01
AR240824A1 (es) 1991-02-28
IE56784B1 (en) 1991-12-18
ATA29984A (de) 1986-11-15
FI79540C (fi) 1990-01-10
HUT34492A (en) 1985-03-28
NL190581B (nl) 1993-12-01
IL70773A (en) 1988-09-30
SE458611B (sv) 1989-04-17
DE3402642A1 (de) 1984-08-02
LU85184A1 (fr) 1984-10-24
SE8400419L (sv) 1984-07-29
DK35384A (da) 1984-07-29
AU566112B2 (en) 1987-10-08
GB2135305B (en) 1987-03-04
ES8600310A1 (es) 1985-10-01
FI81356B (fi) 1990-06-29
DK162052B (da) 1991-09-09
SK61684A3 (en) 1998-03-04
GR79791B (ko) 1984-10-31
CA1241948A (en) 1988-09-13
GB2135305A (en) 1984-08-30

Similar Documents

Publication Publication Date Title
NL190581C (nl) 7beta-(D-2-amino-2-fenylaceetamido)-3-(propenyl)-3-cefem-4-carbonzuur verbinding en farmaceutisch preparaat dat deze verbinding omvat.
PH21506A (en) New pharmaceutical composition based on valporic acid
DE3577206D1 (de) Fluorpolyetherverbindungen.
KR840009036A (ko) 작용제의 개량된 투약기
DK163958C (da) Analgetiske praeparater indeholdende n-phenylmethyl-cis-monoalkenamider
NO840487L (no) 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansyrer
DE3481313D1 (de) Zusammensetzung aus aethylen-polymeren.
DE3484470D1 (de) Chemisch aktive zusammensetzung ferro-ionen enthaltend.
IT8323634A0 (it) Composizione per fotoriproduzioni.
ATE34383T1 (de) Oxamidsaeure-derivate.
DE3576335D1 (de) Chinolincarbonsaeure-derivate.
NL193022B (nl) N-acyl-alfa-amino-alfa,omega-alkaandicarbonzuuramiden en farmaceutisch preparaat dat een dergelijke verbinding bevat.
IT1209615B (it) Composizione farmaceutica
DE3485582D1 (de) Antioxydierende zusammensetzung.
DK162640C (da) N-piperazinylalkanoylanilider og farmaceutiske kompositioner, der indeholder disse forbindelser
NO164659C (no) 7-amino-3-((z)-1-propen-1-yl)-3-cefem-4-karboksylsyrederivater.
DK499784D0 (da) Cephemderivater.
DE3483294D1 (de) Barbitursaeurederivate.
IT1207046B (it) Sostanze anti-ulcera ad attivita'citoprotettiva.
NO863308D0 (no) Oppbevaringsdisk for "compactdiscs".
DE3679100D1 (de) Cyanalkankarbonsaeureimidamid-verbindungen.
IT8419663A0 (it) Gioco di composizione.
DK617084D0 (da) Prostatriensyrederivater
DE3883747D1 (de) Gelatinzusammensetzung.
FI860449A (fi) Komposition foer behandling av graesmatta.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BB A search report has been drawn up
BT A notification was added to the application dossier and made available to the public
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BK Erratum

Free format text: CORRECTION TO PUBLISHED PAMPHLETS OF EXAMINED PATENT APPLICATIONS

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20040125